Cyfuse Biomedical KK (TSE:4892) Days Sales Outstanding : 0.00 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Days Sales Outstanding?

Cyfuse Biomedical KK's average Accounts Receivable for the three months ended in Dec. 2024 was 円12.40 Mil. Cyfuse Biomedical KK's Revenue for the three months ended in Dec. 2024 was 円0.00 Mil.

The historical rank and industry rank for Cyfuse Biomedical KK's Days Sales Outstanding or its related term are showing as below:

TSE:4892' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.02 Med: 53.07 Max: 127.56
Current: 75.08

During the past 5 years, Cyfuse Biomedical KK's highest Days Sales Outstanding was 127.56. The lowest was 20.02. And the median was 53.07.

TSE:4892's Days Sales Outstanding is ranked worse than
52.82% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.085 vs TSE:4892: 75.08

Cyfuse Biomedical KK's Days Sales Outstanding declined from Sep. 2023 (6.87) to Dec. 2024 (0.00).

Cyfuse Biomedical KK Days Sales Outstanding Historical Data

The historical data trend for Cyfuse Biomedical KK's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Days Sales Outstanding Chart

Cyfuse Biomedical KK Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

53.07

20.02

34.74

91.68

127.56

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial							6.87	25.70	107.37	75.27	-

Competitive Comparison of Cyfuse Biomedical KK's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyfuse Biomedical KK's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Cyfuse Biomedical KK Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cyfuse Biomedical KK's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (17.118	+	20.938)	/	2 )	/	54.446	*	365
=	19.028					/	54.446	*	365
=	127.56

Cyfuse Biomedical KK's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (3.87	+	20.938)	/	2 )	/	0	*	365 / 4
=	12.404					/	0	*	365 / 4
=	N/A

Cyfuse Biomedical KK (TSE:4892) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cyfuse Biomedical KK Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN

Website

https://www.cyfusebio.com

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK Headlines

No Headlines